Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

EU supports creation of a European cancer research area

19.09.2002


How to build greater coherence in European cancer research? This is the key question to be debated at a conference today, which brings together around 250 representatives from science, the medical profession, government, patient organisations, foundations, industry and European institutions.



The aim of the conference, jointly organised by the European Commission and the European Parliament, is to kick-off the conception of a joint European strategy for cancer research, rallying all actors concerned to improve the coherence and efficiency of their research activities. The conference coincides with the launch, in November 2002, of the EU’s Sixth Research Framework Programme (2002–2006), which has been designed to better structure and integrate the excellent science that Europe already has.

Opening the conference together with the Parliament’s president Pat Cox and Member of Parliament Wim Van Velzen, EU Research Commissioner Philippe Busquin said: “Cancer kills more than 750.000 people a year. The EU is ready to invest up to € 400 million in cancer research over the next 4 years. But our investments will only bear fruit if researchers and funding agencies from across Europe work together with common goals. We need to innovate in the way we organise research at European level. Only then will we be able to quickly translate the phenomenal advances in science into practical and meaningful early stage diagnosis and therapies for patients.”


MEP Wim Van Velzen added: “I am convinced that with a common effort and bundling of initiatives, we can do more and better in Europe. Europe has the potential to combat cancer more effectively. Let’s use it.”

Cancer is still a huge burden on European citizens. Although it is difficult to consolidate figures for Europe , it is known that 240.000 new cases are detected in France each year and that cancer is responsible for 24% of all deaths in the UK.
Considerable resources are devoted to fighting cancer throughout Europe. Yet these efforts are not producing the results that health practitioners and citizens might expect, at a time when basic science is advancing fast in understanding the fundamentals of human life. This is partly due to the fragmentation and duplication of research efforts within Member states and across Europe and the lack of co-ordination at European level.

The EU’s Sixth Framework Programme provides the means to catalyse the realisation of a European cancer research area. Thanks to the active support of Parliament, cancer research is a priority within the health research field for which up to €400 million has been earmarked. Although this represents a relatively modest proportion of the funds spent on cancer research throughout Europe, these resources and the new funding tools of the Framework Programme offer opportunities to co-ordinate research efforts undertaken in publicly and privately funded research institutions, to extend research networks and to tackle common problems.

The EU will support researchers to mount large networks of excellence that bring together the best teams of researchers and clinical practitioners to develop and validate new therapies and interventions. Through integrated projects, sufficient critical mass of expertise and resources can be directed at subjects such as the development of relevant pre-clinical tests to evaluate new therapies or the validation of molecular targets for cancer diagnosis and treatment. Research institutes will be able to attract the world’s leading experts in a certain field through a revamped European scheme for the mobility of researchers. The Commission will also support the co-ordination of national and regional research programmes.

A European strategy for cancer research should also explore how the framework conditions for cancer research in Europe can be improved. One case in point is the organisation of multi-national clinical trials. Commissioner Busquin said: “Europe’s diversity in populations, life-style and disease patterns places us in a unique position to advance the understanding and treatment of cancer. But co-ordination is needed between researchers, hospitals and regional or national authorities to deal with diverging regulatory, ethical and other procedures.”

The conference will enable a broad range of stakeholders in cancer research with an opportunity to present their respective roles and expectations and to make proposals to support the co-operation and co-ordination of cancer research in Europe. The Commission will use the outcome of this consultation to propose a strategy for a European cancer research area.

Stéphane Hogan | alfa

More articles from Health and Medicine:

nachricht Rabies viruses reveal wiring in transparent brains
19.01.2017 | Rheinische Friedrich-Wilhelms-Universität Bonn

nachricht On track to heal leukaemia
18.01.2017 | Universitätsspital Bern

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Traffic jam in empty space

New success for Konstanz physicists in studying the quantum vacuum

An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...

Im Focus: How gut bacteria can make us ill

HZI researchers decipher infection mechanisms of Yersinia and immune responses of the host

Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...

Im Focus: Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.

While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...

Im Focus: Studying fundamental particles in materials

Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales

Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...

Im Focus: Designing Architecture with Solar Building Envelopes

Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.

As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Sustainable Water use in Agriculture in Eastern Europe and Central Asia

19.01.2017 | Event News

12V, 48V, high-voltage – trends in E/E automotive architecture

10.01.2017 | Event News

2nd Conference on Non-Textual Information on 10 and 11 May 2017 in Hannover

09.01.2017 | Event News

 
Latest News

New Study Will Help Find the Best Locations for Thermal Power Stations in Iceland

19.01.2017 | Earth Sciences

Not of Divided Mind

19.01.2017 | Life Sciences

Molecule flash mob

19.01.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>